Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-25 @ 11:57 PM
NCT ID: NCT00494494
Description: Serious and/or other adverse Events were not collected for this study.
Frequency Threshold: 0
Time Frame: None
Study: NCT00494494
Study Brief: Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Treatment These subjects only received the standard of care for post-operative cataract, which consists of a topical antibiotic and a topical corticosteroid. None None 0 0 0 0 View
Nepafenac 1 drop per study eye three times per day for 30 days plus standard care None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):